Sponsored Links
| Lack Of Efficacy In Reducing Cardiovascular Events Prompts NIH Decision To Stop Clinical Trial On Combination Cholesterol Treatment |
 |
 |
 |
| Medical News - Cholesterol | |||
|
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular events, including heart attacks and stroke... Read more: Cholesterol News From Medical News Today
|